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Immune cellsLiver regeneration is controlled by a complex network of signalingmolecules, and a prominent role for c-jun
N-terminal kinase has been suggested during this process. In the present study, we aimed to characterize and
deﬁne the cell-type-speciﬁc contribution of JNK1 activation during liver regeneration. We used hepatocyte-
speciﬁc JNK1 knockout mice (JNK1Δhepa) using the cre/lox-P system. We performed partial hepatectomy (PH)
in WT, JNK1Δhepa and JNK1−/− animals and investigated time-points up to 72 h after PH. Additionally, bone
marrow transplantation experiments were conducted in order to identify the contribution of hematopoietic
cell-derived JNK1 activation for liver regeneration. Our results show that liver regeneration was signiﬁcantly
impaired in JNK1−/− compared to JNK1Δhepa andWT animals. These data were evidenced by lower BrdU incorpo-
ration and decreased cell cycle markers such as Cyclin A, Cyclin D, E2F1 and PCNA 48 h after PH in JNK1−/−
compared with JNK1Δhepa and WT livers. In JNK1−/− mice, our ﬁndings were associated with a reduced
acute phase response as evidenced by a lower activation of the IL-6/STAT3/SAA-1 cascade. Additionally,
CD11b+Ly6G+-cells were decreased in JNK1−/− compared with JNK1Δhepa and WT animals after PH. The
transplantation of bone marrow-derived JNK1−/− into WT recipients caused signiﬁcant reduction in liver
regeneration. Interestingly, the transplantation of JNK1−/− into mice lacking JNK1 in hepatocytes only partially
delayed liver regeneration. In summary, we provide evidence that (1) JNK1 in hematopoietic cells is crucial for
liver regeneration, and (2) a synergistic function between JNK1 in hepatocytes and hematopoietic-derived cells is
involved in the hepatic regenerative response.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The regenerative capacity is dormant in a healthy liver. However,
surgical resection, drug intoxication or viral infections trigger a complex
process with the ultimate aim to restore liver mass and cell function. In
rodents, the preferred experimentalmodel to study liver regeneration isnine aminotransferase; AP-1,
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edicine III, University Hospital,
y.two-thirds partial hepatectomy (PH). This model is highly reproducible,
consists of a controlled sequence of events and has direct clinical implica-
tions [1]. In fact, in humans, liver resection is frequently performed during
surgery of liver metastases or repair after liver trauma [2].
Partial resection of the liver triggers activation of the c-Jun N-terminal
kinases (JNK), members of the mitogen-activated protein kinase (MAPK)
family [3,4]. The TNF-mediated activation of JNKwithin 1 h after PH leads
to the activation of AP-1,which, in turn, promotes the expressionof Cyclin
D, initiating G0-G1 transition and, thus hepatocyte proliferation [3–7].
In contrast to the central role of JNK in promoting liver regeneration,
persistent JNK activation attenuates liver regeneration, clearly suggesting
that themagnitude and duration of JNK activation is a critical regulator of
liver homeostasis.3
Cell-type-speciﬁc ablation using the cre/lox-P system has helped to
improve the understanding of the speciﬁc functions of JNK in distinct
tissues and the interaction between the liver and other organs [7,8].
This is of clinical relevance since targeted pharmacological modulation
of JNK function might be beneﬁcial for patients with malignant liver
tumors.
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the cell-type-speciﬁc contribution of JNK1 activation during liver regen-
eration using the two-thirds PH model. We addressed this task by
combining global and hepatocyte-speciﬁc JNK1 knockout animals.
Additionally, we performed bone marrow transplantation (BMT) to
ﬁnally establish that whereas JNK1 in hematopoietic cells is crucial for
liver regeneration, JNK1 in hepatocytes alone is irrelevant. However, a
synergistic functionbetween JNK1 in hematopoietic cells andhepatocytes
is necessary for restoring liver mass.
2. Methods
2.1. Housing, generation of knockout mice and bonemarrow transplantation
Animals were maintained in the animal facility of the University
Hospital RWTH Aachen according to the German legal requirements.
Wild-type (WT), constitutive JNK1−/− animals as well as hepatocyte-
speciﬁc knockout mice JNK1Δhepa were bred in a deﬁned C57BL/6
background. Genotypes were conﬁrmed via PCR for the respective
genes. Genotypes were conﬁrmed by PCR analysis of genomic DNA.
We transferred bone marrow from JNKΔhepa and JNK1−/−mice into 6-
to 7-week-old JNK1−/− and WT isogeneic recipients (n= 6–7 mice per
group) after ablative γ-irradiation, as described previously [7,9].
2.2. Partial hepatectomy
Two thirds partial hepatectomy (PH) as described previously1
was performed in male mice in the age of 7 to 8 weeks. Animals were
euthanized after varying periods of time. Control samples were taken
from explanted livers of the respective strains at the time of PH.
2.3. Immunoblot analysis
Protein extracts were electrophoresed and then blotted following
standard procedures. Blots were incubated with primary antibodies
anti-Ccn D1, anti-Ccn A2 (Santa Cruz Biotechnology, Santa Cruz, CA)
and anti-pSTAT3 from Cell Signaling (Beverly, MA). As secondary
antibodies, anti-rabbit-HRP (Cell Signaling) and anti-mouse-HRP (Santa
Cruz) were used. GAPDH from AbD SeroTec (Düsseldorf, Germany) was
used as loading control.
2.4. Quantitative real-time PCR
Total RNA was puriﬁed from liver tissue using Trizol reagent
(Invitrogen, Karlsruhe, Germany). Total RNA (1 μl) was used to
synthesize cDNA using SuperScript ﬁrst-Stand Synthesis System
(Invitrogen, Karlsruhe, Germany) and was resuspended in 100 μl of
H2O. Quantitative real-time PCR was performed using SYBR Green
Reagent (Invitrogen, Karlsruhe, Germany) in 7300 real-time PCR system
(Applied Biosystem, Darmstadt, Germany). GAPDH expressionwas used
to normalize gene expression in a given sample which is represented as
fold induction versus WT basal expression in control samples. Primers
can be provided upon request.
2.5. Histological, immunoﬂuorescence analysis
Livers from mice were harvested and, following ﬁxation with 4%
PFA, were embedded in parafﬁn for further histological evaluation.
H&E staining was performed on parafﬁn-embedded liver sections.
Samples were reviewed by a blinded pathologist who analyzed the
degree of liver injury. For immunoﬂuorescence staining, liver cryosec-
tions of 5 μm were stained with CD11b (Santa Cruz, Heidelberg,
Germany), Oil Red O or anti-BrdU antibody as previously described [1].
Examination was performed using a Leica automatic stainer (Wetzlar,
Germany).Mounting solution containing 4′,6′-diamidino-2-phenylindole
(DAPI) (Vector Laboratories, Burlingame, CA) was used to counterstainthe nuclei of hepatocytes and incubated with ﬂuorescence labeled
secondary antibodies (AlexaFluor 488 and 564, Invitrogen, Carlsbad, CA,
USA).
2.6. Flow cytometry analysis
Immune cells from whole liver were isolated and stained with
ﬂuorochrome-conjugated antibodies (CD4-PE, CD3-APC, NK1.1/PE/Cy7,
CD8-FITC, CD45-APC-Cy7, CD11b-PE, CD11c-APC, Ly6G-FITC, CD19-
PERCP/Cy5.5, Gr1.1 PERCP/Cy5.5 and F4/80-Bio/Streptomycin/Cy7) (BD
Biosciences, Heidelberg, Germany). All samples were acquired by ﬂow
cytometry (FACS Canto II; BD Biosciences) and analyzed using the
Flowjo® software.
2.7. General procedures
SerumALT, AST, cholesterol, glucose and triglycerides were processed
by the Central Laboratory Facility at University Hospital RWTH Aachen.
Blood counts were performed by the Central Laboratory Facility for
laboratory animals at University Hospital RWTH Aachen.
2.8. Statistical analysis
Data are expressed as the mean ± SD. Statistical signiﬁcance was
determined via one- and two-way analysis of variance (ANOVA) followed
by a Bonferroni test. Statistics regarding the BrdU stainings were
determined via unpaired T-test.
3. Results
3.1. Liver regeneration after partial hepatectomy is independent of
hepatocyte-derived JNK1
Following liver resection, hepatocyte proliferation starts in areas of
the lobules surrounding the portal triads and then proceeds to the
pericentral areas 36 to 48 after PH [10]. Thus, we studied DNA synthesis
48 h after surgery and ﬁrst examined bromodeoxyuridine incorporation
(BrdU). As expected, BrdU incorporation was signiﬁcantly decreased in
JNK1−/− comparedwithWT and JNK1Δhepa mice, 48 h after PH (Fig. 1a).
This reduction was consistent with the lower number of mitotic ﬁgures
we observed at this time point in the H&E staining (Supplementary
Fig. 1). Moreover, we analyzed cyclin A protein expression (Fig. 1b)
and also included other cell cycle markers such as Cyclin D, E2F1 and
PCNA, which showed that hepatic regeneration is strongly reduced in
JNK1−/− compared with JNK1Δhepa and WT mice (Fig. 1c–e).
To better characterize the differences between JNK1Δhepa and JNK1−/−
livers, we examined in more detail the course of liver regeneration up to
72 h after PH (Suppl. Fig. 1). We observed that JNK1−/− and JNK1Δhepa
knockout mice displayed lower BrdU incorporation compared with WT
mice 72 h after PH (Fig. 2a + b). Furthermore, liver injury as evidenced
by serum transaminases was less prominent in JNK1−/− compared with
JNK1Δhepa and WT mice (Fig. 2c). However, we found no differences in
liver versus body weight (LW/BW) ratio at this time point (Fig. 2d).
3.2. IL-6/SAA-1/STAT-3 activation is decreased in JNK1−/− mice after
partial hepatectomy
Partial hepatectomy (PH) causes JNK activation and a robust
regenerative response to restore liver mass [5]. First, Hui [11] and later
Das [8] have clearly demonstrated that JNK1−/− knockout mice show
impaired liver regeneration. IL-6-dependent STAT-3 activation plays a
physiological role in promoting hepatic survival by stimulating prolifera-
tion of hepatocytes in a paracrine manner, speciﬁcally via inducing the
acute phase response [12–14]. Thus, we examined whether the defect
in liver regeneration in JNK1−/− mice was associated with changes in
STAT-3/IL-6 activation (Fig. 3).
Fig. 1. Liver regeneration after partial hepatectomy is independent of hepatocyte-derived JNK1. (a) BrdU immunoﬂuorescence stainingwasperformed inWT, JNK1−/− and JNK1Δhepamice,
48 h after PH (20×). Quantiﬁcation of BrdU-positive cells was graphed and presented. (b) Western blot was performed to detect cyclin A expression in liver extracts isolated fromWT,
JNK1−/− and JNK1Δhepa livers 48 h after PH. GAPDH was used as loading control. mRNA levels of cyclin D1 (c), PCNA (d) and E2F1 (e) were determined using qRT-PCR expression of
GAPDH mRNA was used to normalize gene expression (***P b 0.001; **P b 0.01; *P b 0.05, n= 4).
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STAT3 in JNK1−/−were signiﬁcantly decreased comparedwith JNK1Δhepa
and WT mice 6 h after PH (Fig. 3a). Concomitant with STAT3 activation,
we observed decreased SAA-1 mRNA levels in JNK1−/− compared with
JNK1Δhepa mice (Fig. 3b). Furthermore, the mRNA expression of IL-6 wasreduced in JNK1−/− compared with JNK1Δhepa and WT mice (Fig. 3c).
Hence, these data showed an impaired regulation of the acute phase
response (APR) in JNK1 knockout livers.
During liver regeneration in rodents, there is a sequential expression
of several proto-oncogenes such as c-Jun and c-Myc during theﬁrst hours
Fig. 2. Time-course study of liver regeneration after PH (a) BrdU immunoﬂuorescence staining at 72 h after PH was performed, quantiﬁed and represented in a graph. (b) BrdU incorporation
was evaluated throughout liver regeneration inWT, JNK1−/− and JNK1Δhepa mice after PH (20×). (c) ALT levels were collected upon euthanasia. (d) The ratio between the liver and the body
weight of partial-hepatectomized mice after euthanasia is presented (***P b 0.001; **P b 0.01).
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PH. We observed that c-Jun expression was down-regulated in JNK1−/−
compared with JNK1Δhepa and WT mice 6 h after PH (Fig. 3d). Liver
regeneration is accompanied by an increase in c-myc expression which
precedes the synchronous entry of the remaining hepatocytes into thecell cycle [16]. Interestingly, we detected higher c-Myc mRNA levels
in JNK1−/− livers—albeit not signiﬁcant—indicating delayed liver
regeneration in these mice (Fig. 3e). Altogether, these results show
that after PH in JNK1−/− livers the delayed regenerative response
is associated with impaired IL-6/STAT-3 activation.
Fig. 3. The IL-6/SAA-1/STAT-3 pathway is decreased in JNK1−/−mice after partial hepatectomy. (a)Western Blot was performed to detect STAT3 expression in liver extracts isolated from
WT, JNK1−/− and JNK1Δhepa livers at 6 h after PH. GAPDHwas used as loading control. mRNA levels of SAA-1 (b), IL-6 (c), c-Jun (d) and c-Myc (e) were determined by qRT-PCR. GAPDH
mRNA was used to normalize gene expression (**P b 0.01; *P b 0.05, n= 4).
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PH
Inﬁltratingmacrophages togetherwith Kupffer cells (KC) orchestrate
liver regeneration after PH [2]. Macrophages play a critical role in overall
tissue recovery after PH and the impact of immune cell inﬁltration on the
acute phase response (APR) has been shown previously [17]. In order
to study differences in resident and/or inﬁltrating macrophages in
JNK1-deleted animals, we performed FACS analysis and stained for
CD11b+ and Ly6G+-positive cells 48 h after PH (Fig. 4a+b). Our results
showed that CD11b+ Ly6G+-cells are decreased in JNK1−/− compared
with JNK1Δhepa and WT animals 48 h after PH.
It has been shown that during liver regeneration, extrathymic T cells
in the liver are signiﬁcantly activated [18]. Surprisingly, we found
higher amounts of CD4+, NK cells and leukocytes but decreased CD8+
lymphocytes and NK1.1 cells in JNK1−/− compared with JNK1Δhepa
and WT livers (Fig. 4c, Supplementary Fig. 2a–d).
Fat accumulation is a typical feature during PH-induced liver regener-
ation [19]. We examined lipid accumulation in regenerating livers by OilRed O staining. We observed reduced fat accumulation in JNK1−/−
compared with JNK1Δhepa andWT livers. This observation was associated
to lower serum glucose levels (Fig. 4d, Supplementary Fig. 3).
3.4. Bone marrow-derived JNK1 is essential for liver regeneration after PH
Since our results demonstrated that JNK1−/− but not JNK1Δhepa livers
exhibited impaired liver regeneration,we performed bonemarrow trans-
plantation (BMT) to examine whether JNK1 in bone marrow (BM)-
derived cells might be involved to explain impaired liver regeneration
as evidenced in JNK1−/− livers after PH. Bone marrow (BM) derived
fromWT, JNK1−/− or JNK1Δhepa mice was transplanted in JNK1−/−, WT
or JNK1Δhepa animals. After BM, wewaited for 8 weeks to allow complete
restoration of Kupffer cell (KC) with BM-derived cells as previously
described [20]. We then performed PH and investigated the 48 h time-
point after surgery (Fig. 5a–c, Supplementary Fig. 4).
The transplantation of BM derived from WT or JNK1Δhepa animals
into JNK1−/−mice (WT/ JNK1Δhepa JNK1−/−) completely restored liver
regeneration as evidenced by BrdU staining 48 h after PH (Fig. 5a; left
Fig. 4. Inﬁltratingmacrophages and T-cells are reduced in JNK1−/− livers after PH. (a) CD11b immunoﬂuorescence on frozen sectionswas performed to detect residentmonocytes in livers
of WT, JNK1−/− and JNK1Δhepa mice, 48 h after PH (20×). (b) 48 h samples from WT, JNK1−/− and JNK1Δhepa–hepatectomized livers were subjected to FACS analysis to stain for the
myeloid populations. The relative amount of CD11b+ Ly6G+ cells was quantiﬁed and represented in FACS blots. (c) 48 h samples fromWT, JNK1−/− and JNK1Δhepa–hepatectomized livers
were subjected to FACS analysis to stain for the lymphoid populations. The relative amount of CD4+ vs CD8+ cells was quantiﬁed and represented in FACS blots. (d) Oil RedO stainingwas
performed in frozen sections (20×) of WT, JNK1−/− and JNK1Δhepa livers 48 h after PH and the percentage of lipid droplets per area was quantiﬁed (***P b 0.001; **P b 0.01).
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Fig. 5. Bonemarrow-derived JNK1 is essential for liver regeneration. (a)WT bone marrow-derived cells were transplanted into JNK1−/− recipients (left panel). In parallel, JNK1−/− bone
marrow-derived cells were transplanted into WT (center panel) and JNK1Δhepa recipients (right panel). In all groups, 8 weeks after irradiation, mice were subjected to PH and were
sacriﬁced in the following 48 h. BrdU was performed on frozen sections and counterstained with DAPI. (b) BrdU incorporation was quantiﬁed and graphed for comparison (20×).
(c) Serum transaminases (ALT) from the same mice were measured (**P b 0.01).
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with JNK1−/− BM (JNK1−/−WT) displayed a major reduction in liver
regeneration and no signiﬁcant differences in serum transaminaseswere found (Fig. 5a; center panel, Fig. 5b + c, Supplementary Fig. 4b).
Interestingly, the transplantation of BM cells into mice lacking JNK1
in hepatocytes (JNK1−/− in JNKΔhepa) partially reduced liver regeneration,
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non-parenchymal cells (NPCs) seems involved in controlling the regener-
ative response.
4. Discussion
JNK activation has been shown to play an important role during liver
regeneration. TNFR1−/−mice or rats injectedwith an anti-TNF antibody
show reduced liver regeneration which was associated with impaired
JNK activation [4,21] andmore speciﬁcally a critical function of JNKduring
hepatic regeneration has been demonstrated by using JNK inhibitors after
PH4. In agreement with previous reports [8,11], our observations
in JNK1−/− livers indicated decreased liver regeneration 48 h after PH.
In our present study, we focused to better characterize the molecular
mechanisms mediating this effect.
Earlier results demonstrated that after PH, IL-6-dependent pathways
trigger the APR and thereby hepatocyte proliferation. Thus, we ﬁrst
examined IL-6 induction after PH. Interestingly, we observed signif-
icantly increased basal expression of IL-6 and SAA-1 in the livers of
JNK1−/−mice. This observation might be explained by compensatory
JNK2 expression, which is critical in controlling the production of
inﬂammatory cytokines [22]. However, after PH, our results showed
decreased IL-6 expression in JNK1−/− but not in JNK1Δhepa animals
which correlated with a weaker activation of the transcription factor
STAT3. Indeed, both IL-6 and the phosphorylation and activation of
Stat-3 are dependent on the activity of JNK, mainly JNK1 [23–25]. This
observationwas associatedwith changes in the expression of immediate
early genes such as c-Jun andmyc but also affected genes involved in cell
cycle control such as Cyclin A, Cyclin D1, E2F1 and PCNA [14,26–31].
Our results indicate that in JNK1−/−mice, diminished IL-6/STAT-3
activation might be involved in causing impaired G0/G1 phase transi-
tion and the decrease in hepatocyte proliferation after PH. IL-6−/−
mice also display a reduced rate of DNA synthesis due to abnormalities
in G phase after PH [14]. Additionally, JNK1−/− livers elicited lower
mRNA levels of c-Jun associated with delayed regeneration, suggesting
that besides a change in IL-6/STAT-3 activation other pathways might
contribute to thisﬁnding. Our data indicate that the reduced proliferation
observed in JNK1−/− livers cannot be only explained by lack of JNK1
expression in hepatocytes. In turn, the role of JNK2 in liver regeneration
is less clear. Sabapathy et al. [32] demonstrated that loss of JNK2 acceler-
ated liver regeneration, through compensatory proliferation via JNK1.
However, Das' study [8] reported no role for JNK2 in liver regeneration.
To further analyze the function, Davis' group performed PH in mice
with compound deletion of JNK1 and JNK2 in hepatocytes. Whereas
they observed reduced proliferation and number of mitotic ﬁgures in
hepatocyte JNK-deﬁcient mice, no differences in overall liver regenera-
tion was found. These data together with our observations indicate that
(1) the function of JNK2 in hepatocytes is dispensable during liver
regeneration and (2) another tissue rather than the liver is essential for
providing the JNK-speciﬁc function during hepatic reconstitution.
Lipids accumulate in the regenerating liver after PH [33]. We
found that metabolic functions such as glucose levels are diminished
in JNK1−/− mice. In fact, JNK1−/− mice have been reported to have
decreased phosphorylation of insulin receptor substrate-1 (IRS-1)
at Ser307, which ameliorates insulin resistance, and are protected
against HFD-induced hepatocyte injury and steatosis [34,35]. Thus,
it seems very likely that JNK1 mediates insulin resistance independent
of nuclear receptor interactions. In fact, peroxisome proliferator-
activated receptor γ1 (PPARγ1), glucocorticoid receptor (GR) and the
retinoic acid receptors (RXR and RARγ) are the only nuclear receptor
described as JNK substrates rather than liver X receptor (LXR) or
farnesoid X receptor (FXR), transcription factors activated after liver
resection [36]. Overall, these data indicate that the lower lipid
accumulation observed in JNK1−/−might contribute to improved insulin
sensitivity and reduced mitotic rate as well as impaired hepatocyte pro-
liferation after PH.Our results using JNK1Δhepa animals demonstrated that the obser-
vations found in JNK1−/− livers cannot be explained by lack of JNK1
expression in hepatocytes. Similar results hadbeen described previously.
Despite a reduction in the mitotic rate, compound JNK1 and JNK2
deﬁciency in hepatocytes did not affect overall liver regeneration [8]. In
contrast to our results, the same group found that compound JNK1 and
JNK2 deﬁciency in hepatocytes plus in non-parenchymal cells did not
prevent liver regeneration. However, they identiﬁed a protective role
for JNK in hepatocytes but deleterious in NPCs after treating the same
mice with DEN. These contradictory results may be explained by the
differential expression of cytokines during liver regeneration and
tumor development. However, it is very plausible that the function of
JNK1 and JNK2 in hepatocytes or NPCs might be dependent on the
experimental model used. Altogether, from our present study, we can
conclude that hematopoietic-derived JNK1 is a crucial determinant for
hepatocyte proliferation after PH.
Immune-mediated mechanisms are strongly activated during
liver regeneration, e.g., via induction of the APR consequently
contributing to hepatocyte proliferation. In JNK1−/− mice, we
observed a decreased number of CD11b-positive—TNF-producing
cells—and signiﬁcant changes were evident in the T-cell ratio of
CD4- and CD8-positive T-cells. It is now generally accepted that
bone marrow-derived cells play a fundamental role during liver
regeneration after PH. Indeed, Fuji et al. (2010) reported a strong
increase in the CD11b population after partial resection. Furthermore,
JNK is required for the differentiation of pro-inﬂammatory macro-
phages and the promotion of the Th1 response [37–39]. Concomitantly,
the deletion of JNK1 in hematopoietic cells decreases cell inﬁltration as
well as proliferation in an experimental model of chronic liver injury
where the regenerative stimulus is the death of hepatocytes [22].
Thus, all these data suggest that JNK1 in hematopoietic cells may
contribute to the recruitment, inﬁltration and proliferation of inﬂam-
matory cells in the regenerating liver.
Concomitant with the study of Das et al. [8], our results indicated
that lack of JNK1 expression in hepatocytes alone is not required
for hepatic regeneration. Thus, we next focused on the identiﬁcation
of the tissue mediating the JNK1-dependent effect required for phys-
iological liver regeneration. The BMT experiments identiﬁed that
JNK1 in hematopoietic cells mediate a pro-proliferative effect after
PH. Different studies have indicated that BM-derived cells are
required to restore liver mass during liver regeneration. Among
them, deﬁciency of TNF in BM-derived cells seems to impair the
regenerative response after PH [40].
Up to now, the identity of the tissue-derived function of JNK1
has remained unknown. Some authors have speculated that the
hypothalamus might directly inﬂuence liver regeneration and thus
might be a likely candidate [41]. The major physiological functions
of JNK1 have been associated to peripheral tissues rather than to
hepatic areas [7,8,42–44].
Our data suggest that JNK in hematopoietic cells has a dominant
function in stimulating the proliferative response during liver regenera-
tion after PH. Loss of JNK1 in BM-derived cells caused delayed regenera-
tion. In contrast, JNK1deletion in hepatocytes alone has no impact on the
proliferative response but acts synergistically to JNK1 in hematopoietic
cells. The contribution of JNK1 from different tissues to the overall
process of liver regeneration after injury has been already reported by
our lab [22]. However, we cannot exclude the possibility that cell-type-
speciﬁc JNK-derived effects affect also the expression of c-Jun. In the
present study,we show that global JNK1 deletion signiﬁcantly decreased
c-Jun expression, whereas JNK1 deﬁciency in hepatocytes did not affect
c-Jun expression. Thus, other authors [45] have raised the possibility
that JNK-dependent signaling has partial redundancy with other
pathways such as p38.
In summary, the role of JNK1 during liver regeneration seems to
be more complex than originally thought as different tissues in a JNK1-
dependent manner contribute to liver regeneration after PH.
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